Investigation of the in vitro antibacterial effects of statins;Stati̇nleri̇n i̇n vi̇tro anti̇bakteri̇yel etki̇nli̇ǧi̇ni̇n araştirilmasi

Mikrobiyoloji Bulteni

Volumn 44, Issue 1, 2010, Pages 161-163

  Çoban, Ahmet Yilmaz ^a   Tekeli, Hacer Özlem ^a   Güney, Akif Koray ^a   Durupinar, Belma ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

Antibacterial effect; Gram negative bacteria; Gram positive bacteria; Statins

Indexed keywords

ATORVASTATIN; HEPTANOIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PYRROLE DERIVATIVE; SIMVASTATIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG EFFECT; HUMAN; LETTER; MICROBIOLOGICAL EXAMINATION;

BACTERIA; DRUG RESISTANCE, BACTERIAL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MICROBIAL SENSITIVITY TESTS; PYRROLES; SIMVASTATIN;

EID: 77749343103     PISSN: 03749096     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)

1. Majumdar SR, McAlister FA, Eurich DT, Padwal RS, Marrie TJ. Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study. BMJ 2006; 333: 999-1004.
2. Hackam DG, Mamdani M, Li P, Redelmeier DA. Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis. Lancet 2006; 367: 413-8.
3. Almog Y, Novack V, Eisinger M, Porath A, Novack L, Gilutz H. The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases. Crit Care Med 2007; 35: 372-8.
4. th ed. CLSI, Wayne, Pa.
5. Grellier P, Valetin A, Millerioux V, Schrevel J, Rigomer D. 3-hydroxy-3-methylglutary1 coenzyme A reductase inhibitors lovastatin ve simvastatin inhibit in vitro development of Plasmodium falciparum and Babesia divergens in human erythrocytes. Antimicrob Agents Chemother 1994; 38: 1144-8.
6. Pradines B, Torrentino-Madamet M, Fontaine A, et al. Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum. Antimicrob Agents Chemother 2007; 51: 2654-5.
7. Botelho-Nevers E, Rolain JM, Espinosa L, Raoult D. Statins limit Rickettsia conorii infection in cells. Int J Antimicrob Agents 2008; 32: 344-8.
8. Thomsen RW, Riis A, Kornum JB, Christensen S, Johnsen SP, Sorensen HT. Preadmission use of statins and outcomes after hospitalization with pneumoniae: population-based cohort study of 29.900 patients. Arch Intern Med 2008; 168: 2081-7.
9. Falagas ME, Makris GC, Matthaiou DK, Rafailidis PI. Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother 2008; 61: 774-85.
10. Jerwood S, Cohen J. Unexpected antimicrobial effect of statins. J Antimicrob Chemother 2008; 61: 362-4.